4.5 Review

Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials

Journal

PROGRESS IN RETINAL AND EYE RESEARCH
Volume 82, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.preteyeres.2020.100907

Keywords

Retina; Microperimetry; FCP; Age-related macular degeneration; Inherited retinal diseases; Inherited retinal dystrophy; Functional outcome measures

Categories

Funding

  1. German Research Foundation (DFG) [PF950/1-1]
  2. National Institute for Health Research (NIHR) Clinical Doctoral Research Fellowship [CA-CDRF-2016-02-002]
  3. Research to Prevent Blindness, New York, NY

Ask authors/readers for more resources

Fundus-controlled perimetry allows for spatially-resolved mapping of visual sensitivity and measurement of fixation stability, providing insightful information about disease severity and progression. Improved intra- and inter-session retest-variability, design of disease-specific test patterns, and advancements in photoreceptor-specific testing are key advantages of this technique. Knowledge of available devices and test settings is crucial for designing and optimizing protocols in future studies and trials.
Fundus-controlled perimetry (FCP, also called 'microperimetry') allows for spatially-resolved mapping of visual sensitivity and measurement of fixation stability, both in clinical practice as well as research. The accurate spatial characterization of visual function enabled by FCP can provide insightful information about disease severity and progression not reflected by best-corrected visual acuity in a large range of disorders. This is especially important for monitoring of retinal diseases that initially spare the central retina in earlier disease stages. Improved intra- and inter-session retest-variability through fundus-tracking and precise point-wise follow-up examinations even in patients with unstable fixation represent key advantages of these technique. The design of disease-specific test patterns and protocols reduces the burden of extensive and time-consuming FCP testing, permitting a more meaningful and focused application. Recent developments also allow for photoreceptor-specific testing through implementation of dark-adapted chromatic and photopic testing. A detailed understanding of the variety of available devices and test settings is a key prerequisite for the design and optimization of FCP protocols in future natural history studies and clinical trials. Accordingly, this review describes the theoretical and technical background of FCP, its prior application in clinical and research settings, data that qualify the application of FCP as an outcome measure in clinical trials as well as ongoing and future developments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available